Current campaigns

Have your say on PBS listings for IBD medications – May/June 2020

The Pharmaceutical Benefits Advisory Committee (PBAC) is seeking consumer feedback on submissions relating to some IBD medications on the Pharmaceutical Benefits Scheme (PBS).

You may like to provide feedback if you have experience taking Adalimumab biosimilar – Hadlima®:


Submission Type:
Change to listing – (Minor Submission)

Drug Name:
ADALIMUMAB

Form(s) & strength(s):
Injection 40 mg in 0.8 mL pre-filled syringe
Injection 40 mg in 0.8 mL single dose autoinjector

Trade Name:
Hadlima®

Sponsor:
Merck, Sharp & Dohme (Australia) Pty Ltd

Drug Type & Use:
Severe active rheumatoid arthritis; Severe psoriatic arthritis; Ankylosing spondylitis; Severe chronic plaque psoriasis; Juvenile idiopathic arthritis; Severe crohn’s disease; Refractory fistulising crohn’s disease; moderate to severe hidradenitis suppurativa

Listing requested by Sponsor / Purpose of Submission:
To request an extension to the currently approved PBS listing of Hadlima to include all indications for which Humira is currently PBS listed.


If you would like to provide information on the impact of proposed changes you can email [email protected] and CCA will forward your comments grouped with those of others to PBAC.

The closing date for comments to CCA is 8 June 2020.

Have your say to support the PBS listings of Adalimumab biosimilar – Hyrimoz®, Mesalazine suppositories and granules – Pentasa®, protein formula – Modulen IBD® or Tofacitinib – Xeljanz®.

Submissions closed

Have your say to support the PBS listing of Stelara for treatment of Crohn’s disease in adults

Submissions closed

Have  your say and let the PBS know your needs for treatment of ulcerative colitis

Submissions closed

Have  your say and support the PBS listing of Humira for treatment of Ulcerative Colitis

Submissions closed

Have your say about getting Vedolizumab on the PBS listing for treatment of Crohn’s disease and ulcerative colitis! 

Submissions closed

Have your say and support the PBS listing of Humira for treatment of paediatric Crohn’s!

Submissions closed